Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 26)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for GEVA11$25  View Abstract
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49  View Abstract
24-Apr-14New Constructs, LLCN/AGEVA: Due Diligence Review: Forensic Earnings and Valuation5$25  View Abstract
19-Apr-14Pechala's ReportsFrantisek PechalaSYNAGEVA BIOPHARMA CP (GEVA) 12-months forecast1$15  View Abstract
17-Apr-14Ford Investor Services, Inc.N/AValue Graph: SYNAGEVA BIOPHAR -- GEVA1$11.50  View Abstract
17-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: FOLD , CNDO , HALO , OREX , GEVA , VNDA -- DRUGS3$34.50  View Abstract
13-Apr-14TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SYNAGEVA BIOPHARMA CORP (GEVA)5$10  View Abstract
12-Apr-14Alpha Street ResearchHunter OrrGEVA - Synageva BioPharma Corp - Downgraded to a Sell - Company Analysis and ASR Ranking Report9$24  View Abstract
9-Apr-14Zacks Investment Research Inc.N/ASYNAGEVA BIOPHM (GEVA) Zacks Company Snapshot1$11.50  View Abstract
8-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Synageva Biopharma Corp42$75  View Abstract
Next 16

Independent Reports (Showing 1 to 10 of 26)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for GEVA11$25View Abstract
24-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49View Abstract
24-Apr-14New Constructs, LLCN/AGEVA: Due Diligence Review: Forensic Earnings and Valuation5$25View Abstract
19-Apr-14Pechala's ReportsFrantisek PechalaSYNAGEVA BIOPHARMA CP (GEVA) 12-months forecast1$15View Abstract
17-Apr-14Ford Investor Services, Inc.N/AValue Graph: SYNAGEVA BIOPHAR -- GEVA1$11.50View Abstract
17-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: FOLD , CNDO , HALO , OREX , GEVA , VNDA -- DRUGS3$34.50View Abstract
13-Apr-14TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SYNAGEVA BIOPHARMA CORP (GEVA)5$10View Abstract
12-Apr-14Alpha Street ResearchHunter OrrGEVA - Synageva BioPharma Corp - Downgraded to a Sell - Company Analysis and ASR Ranking Report9$24View Abstract
9-Apr-14Zacks Investment Research Inc.N/ASYNAGEVA BIOPHM (GEVA) Zacks Company Snapshot1$11.50View Abstract
8-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Synageva Biopharma Corp42$75View Abstract
Next 16

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.